Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

The singular confirmed case was isolated, but Campus Health leadership warned that communicable diseases can spread quickly ...

February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...

Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.

A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly ...

Worried about measles? The CDC recommends children receive two doses of the vaccine. Here's what you should know about the vaccine and where to get it.

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

The history of the hepatitis B vaccine has been marked by controversies, from the ‘Australia antigen’ to the ‘Pediatric ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.